Cardiovascular

Young adults less likely to be diagnosed with hypertension than over 60s+

31st December 2012

LOS ANGELES—Half of young adults who had multiple, elevated, blood pressure results on recent outpatient visits to the doctor, went home without a hypertension diagnosis. Research presented at the 2012 American Heart Association meeting showed, after four years of trips …

Read More+

More cardiac deaths in the winter — no matter the climate+

31st December 2012

LOS ANGELES—Regardless of climate, there are more deaths from heart-related issues in winter-time than in the summer. Results from a 12-year US population based study with over 220,000 people were presented at the American Heart Association meeting in Los Angeles …

Read More+

Aging signs predict coronary risk independently of chronological age+

31st December 2012

LOS ANGELES—Looking older than your chronological age is a risk factor for cardiovascular disease — at least among white Caucasians — according to a study of over ten thousand Danish people from the general population who were…

Read More+

GAUSS STUDY: New alternative for LDL lowering in patients intolerant to statins+

16th November 2012

LOS ANGELES—A more powerful back-up drug for patients intolerant to statins was announced at the American Heart Association 2012 Scientific Sessions. A monoclonal antibody called: AMG 145 against a protein found to regulate LDL receptor activity — the PCSK 9 …

Read More+

Pregnancy hormone helps hospitalised patients with acute heart failure+

16th November 2012

LOS ANGELES—A recombinant form of the human hormone relaxin — active in pregnancy to optimise the mother’s cardiovascular capacity — may help patients hospitalised for acute heart failure, according to findings discussed at the American Heart Association’s 2012 Scientific Sessions …

Read More+

Direct infusions of HDL to prevent re-infarction in patients with acute coronary syndromes+

16th November 2012

LOS ANGELES—Direct infusions of human HDL — to speedily boost HDL levels —could be an answer to preventing re-infarction in patients who’ve just had a heart attack and are at high risk of having another, according to conclusions from a …

Read More+

Important new role for aspirin: prevention of recurrent thromboembolism: ASPIRE findings+

12th November 2012

LOS ANGELES—Aspirin has a new role: in preventing recurrent thromboembolism among patients who are not candidates for anti-coagulation — according to conclusions from the ASPIRE study reported to the American Heart…

Read More+

Polypill—even better for coronary prevention among those at high risk+

12th November 2012

LOS ANGELES—The “polypill” — a multi-drug pill — combining diuretic, ACE inhibitor, beta-blocker, statin and aspirin — brings even more benefit when it’s targeted at patients who are at elevated coronary risk rather than being used as a general “insurance” …

Read More+

CABG better than pci in patients with diabetes and multi-vessel coronary disease+

10th November 2012

LOS ANGELES—The optimal revascularisation strategy for patients with diabetes and multi-vessel coronary disease was confirmed to be coronary artery bypass grafting rather than PCI at the American Heart Association 2012 Scientific Sessions…

Read More+

Reversible ADP Antagonists: New Alternatives To Clopidogrel For Anti-Platelet Therapy In Elective PCI+

24th November 2009

ORLANDO—Deepak Bhatt from the VA Boston Healthcare System and Brigham & Women’s Hospital, talks with Peter Goodwin about findings from the CHAMPION-PLATFORM study (using cangrelor in PCI) and the PLATO study (with ticagrelor in ACS)—testing reversible ADP antagonist agents …

Read More+

Central Pressure And New Goals: Should Be Hypertension Therapy Priorities+

6th July 2009

A fundamental change in the way hypertension is measured, and studies to identify evidence-based blood pressure goals have been highlighted as top priorities by one of Sweden’s prominent hypertension specialists, Björn Dahlöf, during the European Meeting on Hypertension.

MILAN—New …

Read More+

Angiotensin AT2 Receptor Agonist: Restorative Role For Patients With Hypertension?+

29th June 2009

The illusive angiotensin AT2 receptor could become an important new target for therapy in the overall care of patients with hypertension. A leading researcher in cardiovascular medical science has found that by stimulating this receptor his group discovered remarkable regenerative …

Read More+